SCHEMBL56397

SCHEMBL56397

C1NCC2CC1C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14523284 1.00
Hydrochloric Acid SCHEMBL20534633 0.96
SCHEMBL233307 0.91
SCHEMBL14673280 0.87 CHRNB2 (0.42)
SCHEMBL6991791 0.87 CHRNB2 (0.42)
SCHEMBL27316 0.84
SCHEMBL15193376 0.84
SCHEMBL12557686 0.83 CHRNB2 (0.43)
SCHEMBL22259922 0.83 CHRNB2 (0.46)
SCHEMBL26093923 0.83 CHRNB2 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 421 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12479827-B2 Heteroaromatic carboxamide derivatives as plasma kallikrein inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2025-11-25 US claimed
CN-116120287-B Heteroaromatic carboxamide derivatives as inhibitors of plasma kallikrein 勃林格殷格翰国际有限公司 2025-01-28 CN claimed
CN-118556047-A Oxo-isoindolinyl substituted piperidinedione derivative and application thereof 标新生物医药科技(上海)有限公司 2024-08-27 CN claimed
WO-2024140637-A1 OXOISOINDOLINYL SUBSTITUTED PIPERIDINEDIONE DERIVATIVE AND USE THEREOF 标新生物医药科技(上海)有限公司 2024-07-04 WO claimed
CN-117881668-A Compound based on isoindoline substituted glutarimide skeleton and application thereof 标新生物医药科技(上海)有限公司 2024-04-12 CN claimed
US-20240076286-A1 HETEROAROMATIC CARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS BOEHRINGER INGELHEIM INT (DE) 2024-03-07 US claimed
WO-2024032689-A1 COMPOUND BASED ON ISOINDOLINE-SUBSTITUTED GLUTARIMIDE BACKBONE AND USE THEREOF 标新生物医药科技(上海)有限公司 2024-02-15 WO claimed
US-20240002363-A1 HETEROAROMATIC CARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS BOEHRINGER INGELHEIM INT (DE) 2024-01-04 US claimed
US-11760745-B2 Heteroaromatic carboxamide derivatives as plasma kallikrein inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2023-09-19 US claimed
CN-116120287-A Heteroaromatic carboxamide derivatives as inhibitors of plasma kallikrein 勃林格殷格翰国际有限公司 2023-05-16 CN claimed
EP-2945938-B1 3-SUBSTITUTED PYRAZOLES AND USE AS DLK INHIBITORS HOFFMANN LA ROCHE (CH) 2018-03-07 EP claimed
US-20170087137-A1 3-SUBSTITUTED PYRAZOLES AND USES THEREOF GENENTECH, INC. (US) 2017-03-30 US claimed
US-9550777-B2 3-substituted pyrazoles and use as DLK inhibitors GENENTECH, INC. (US) 2017-01-24 US claimed
US-20160002228-A1 3-SUBSTITUTED PYRAZOLES AND USE AS DLK INHIBITORS GENENTECH, INC. (US) 2016-01-07 US claimed
EP-2945938-A1 3-SUBSTITUTED PYRAZOLES AND USE AS DLK INHIBITORS F. Hoffmann-La Roche AG (CH) 2015-11-25 EP claimed
EP-2895484-A1 GLUCOSYLCERAMIDE SYNTHASE INHIBITORS Genzyme Corporation (US) 2015-07-22 EP claimed
WO-2014111496-A1 3-SUBSTITUTED PYRAZOLES AND USE AS DLK INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2014-07-24 WO claimed
WO-2014043068-A1 GLUCOSYLCERAMIDE SYNTHASE INHIBITORS GENZYME CORPORATION (US) 2014-03-20 WO claimed
EP-0281134-B1 CATIONICALLY ESTABLISHED PIGMENT DISPERSION AND BRUSH PAINT MD Papier GmbH & Co. KG (DE) 1992-02-12 EP claimed
WO-1990007503-A1 SUBSTITUTED 3-AZABICYCLO[3.1.1]HEPTANES, THEIR PRODUCTION AND USE BOEHRINGER INGELHEIM KG (DE) 1990-07-12 WO claimed